Drug-induced hepatitis with hepatic granuloma due to saridon

Journal of Gastroenterology

Volumn 37, Issue 12, 2002, Pages 1068-1072

  Abe, Masanori ^a   Kumagi, Teru ^a   Nakanishi, Seiji ^a   Yamagami, Takashi ^a   Michitaka, Kojiro ^a   Abe, Kayo ^b   Okura, Izumi ^b   Yamashita, Haruhiko ^b   Horiike, Norio ^a   Onji, Morikazu ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Yoshida General Hospital   (Japan)

Author keywords

Drug induced hepatitis; Hepatic granuloma; Isopropylantipyrine; Saridon

Indexed keywords

ALKALINE PHOSPHATASE; APRONAL; ASPARTATE AMINOTRANSFERASE; AUTOANTIBODY; CYTOSOL AMINOPEPTIDASE; GAMMA GLUTAMYLTRANSFERASE; PHENACETIN; PROPYPHENAZONE; SARIDON; VIRUS ANTIBODY;

ABDOMINAL SCINTISCANNING; ADULT; ANAMNESIS; ANOREXIA; ARTICLE; CASE REPORT; CELL INFILTRATION; CLINICAL FEATURE; DRUG WITHDRAWAL; EPITHELIUM TUMOR; FEMALE; FEVER; HEADACHE; HUMAN; HUMAN CELL; INFLAMMATORY CELL; LEUKOCYTE COUNT; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER GRANULOMA; LIVER PARENCHYMA; LYMPHOCYTE TRANSFORMATION TEST; MALAISE; PORTAL VEIN; PRIORITY JOURNAL; SYMPTOM; SYMPTOMATOLOGY; TOXIC HEPATITIS;

ADULT; ANTIPYRINE; BIOPSY, NEEDLE; CAFFEINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; FOLLOW-UP STUDIES; GRANULOMA; HEADACHE; HEPATITIS, TOXIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER FUNCTION TESTS; PHENACETIN; PYRIDONES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 0036962872     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350200180     Document Type: Article

References (23)

1. Sherlock S, Dooley J. Diseases of the liver and biliary system. London: Blackwell Science, 1997.
2. Lefkowith JH. Hepatic granuloma. J Hepatol 1999;30(Suppl 1):40-5.
3. Guckian JC, Perry JE. Granulomatous hepatitis: an analysis of 63 cases and review of the literature. Ann Intern Med 1966;35:1081-100.
4. Anderson CS, Nicholls J, Rowland R, LaBrooy J. Hepatic granulomas: a 15-year experience in the Royal Adelaide Hospital. Med J Aust 1988;148:71-4.
5. Sartin JS, Walker RC. Granulomatous hepatitis: a retrospective review of 88 cases at the Mayo Clinic. Mayo Clin Proc 1991;66:914-8.
6. McCluggage WG, Sloan JM. Hepatic granulomas in Northen Ireland: a thirteen-year review. Histopathology 1994;25:219-28.
7. McMaster KR, Hennigar GR. Drug-induced granulomatous hepatitis. Lab Invest 1981;44:61-73.
8. Farrel GC. Drug-induced granulomatous hepatitis. In: Farrel GC, editor. Drug-induced liver disease. London: Churchill Livingstone; 1994. p. 301-17.
9. Chan HL, Wong SN, Tham SN. Fixed drug eruptions-a Singapore study. Ann Acad Med Singapore 1988;17:514-7.
10. Drukker W, Schwarz A, Vanherweghem JL. Analgesic nephropathy: an underestimated cause of end-stage renal disease. Int J Artif Organs 1986;9:219-46.
11. Dohmen K, Matsunaga K, Irie K, Shirahata M, Onohara S, Miyamoto Y, et al. Granulomatous hepatitis induced by saridon and serrapeptase. Hepatol Res 1998;11:133-7.
12. Abrahams C, Wheatley A, Rubstein AH, Stable D. Hepatocellular lipofuscin after excessive ingestion of analgesics. Lancet 1964;11:621-2.
13. Nosal A, Schleisener LA, Mishkin FS, Lieberman J. Angiotensin-1-converting enzyme and gallium scan in non-invasive evaluation of sarcoidosis. Ann Intern Med 1979;4:328-31.
14. Sopena B, Martinez-Vazquez C, Fernandez-Rodriguez CM, de la Fuente J, Rivera A, Rodriguez M, et al. Serum angiotensin converting enzyme and C4 protein of complement as a combined diagnostic index in alcoholic liver disease. Liver 1996;16:303-8.
15. Johnson DA, Diehl AM, Sjogren MH, Lazar J, Cattau EL Jr, Smallridge RC. Serum angiotensin converting enzyme activity elevation in patients with liver disease. Am J Med 1987;83:256-60.
16. Lindgren A, Aldenborg F, Norkrans G, Olaison L, Olsson R. Paracetamol-induced cholestatic and granulomatous liver injuries. J Intern Med 1997;241:435-9.
17. Knobel B, Buyanowsky G, Dan M, Zaidal L. Pyrazinamide-induced granulomatous hepatitis. J Clin Gastroenterol 1997;24:264-6.
18. Colle I, Naegals S, Hoorens A, Hautekeete M. Granulomatous hepatitis due to mebendazole. J Clin Gastroenterol 1999;28:44-5.
19. Braun M, Fraser GM, Kunin M, Salamon F, Kapsa RT. Mesalazine-induced granulomatous hepatitis. Am J Gastroenterol 1999;94:1973-4.
20. Bjornsson E, Olsson R, Remotti H. Norfloxacin-induced eosinophilic necrotizing granulomatous hepatitis. Am J Gastroenterol 2000;95:3662-4.
21. Zimmerman HJ. Classification of hepatotoxins and mechanisms of toxicity. In: Zimmerman HJ, editor. Hepatotoxity. Philadelphia: Lippincott Williams and Wilkins; 1999. p. 111-45.
22. Banks AT, Zimmerman HJ, Ishak KG, Harter JG. Diclofenac-associated hepatotoxicity: analysis of 180 cases reported to the Food and Drug Administration as adverse reactions. Hepatology 1995;22:820-7.
23. Levy M. Propylthiouracil hepatotoxity. Clin Pediatr (Phila) 1993;32:25-9.